Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.

Nagpal K, Singh SK, Mishra DN.

Expert Opin Drug Deliv. 2013 Jul;10(7):927-55. doi: 10.1517/17425247.2013.762354. Epub 2013 Jan 21. Review.

PMID:
23330786
2.

Drug delivery to brain via the blood-brain barrier.

Scherrmann JM.

Vascul Pharmacol. 2002 Jun;38(6):349-54. Review.

PMID:
12529929
3.

Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles.

Patel M, Souto EB, Singh KK.

Expert Opin Drug Deliv. 2013 Jul;10(7):889-905. doi: 10.1517/17425247.2013.784742. Epub 2013 Apr 4. Review.

PMID:
23550609
4.

Vector-mediated drug delivery to the brain.

Temsamani J, Rousselle C, Rees AR, Scherrmann JM.

Expert Opin Biol Ther. 2001 Sep;1(5):773-82. Review.

PMID:
11728213
5.

Ultrasound-mediated strategies in opening brain barriers for drug brain delivery.

Zhao YZ, Lu CT, Li XK, Cai J.

Expert Opin Drug Deliv. 2013 Jul;10(7):987-1001. doi: 10.1517/17425247.2013.787987. Epub 2013 Apr 4. Review.

PMID:
23550691
6.

Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide.

Chacko AM, Li C, Pryma DA, Brem S, Coukos G, Muzykantov V.

Expert Opin Drug Deliv. 2013 Jul;10(7):907-26. doi: 10.1517/17425247.2013.808184. Epub 2013 Jun 11. Review. Erratum in: Expert Opin Drug Deliv. 2013 Oct;10(10):1463.

7.

Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Sanchez-Covarrubias L, Slosky LM, Thompson BJ, Davis TP, Ronaldson PT.

Curr Pharm Des. 2014;20(10):1422-49. Review.

8.

2B-Trans technology: targeted drug delivery across the blood-brain barrier.

Gaillard PJ, de Boer AG.

Methods Mol Biol. 2008;437:161-75. doi: 10.1007/978-1-59745-210-6_8. Review.

PMID:
18369968
9.

Liposomes for brain delivery.

Lai F, Fadda AM, Sinico C.

Expert Opin Drug Deliv. 2013 Jul;10(7):1003-22. doi: 10.1517/17425247.2013.766714. Epub 2013 Feb 4. Review.

PMID:
23373728
10.

Novel models for assessing blood-brain barrier drug permeation.

Geldenhuys WJ, Allen DD, Bloomquist JR.

Expert Opin Drug Metab Toxicol. 2012 Jun;8(6):647-53. doi: 10.1517/17425255.2012.677433. Epub 2012 Apr 3. Review.

PMID:
22468700
11.

Drug penetration across the blood-brain barrier: an overview.

Mangas-Sanjuan V, González-Alvarez M, Gonzalez-Alvarez I, Bermejo M.

Ther Deliv. 2010 Oct;1(4):535-62. Review.

PMID:
22833966
12.

Modern methods for delivery of drugs across the blood-brain barrier.

Chen Y, Liu L.

Adv Drug Deliv Rev. 2012 May 15;64(7):640-65. doi: 10.1016/j.addr.2011.11.010. Epub 2011 Nov 28. Review.

PMID:
22154620
13.

Current approaches for drug delivery to central nervous system.

Hossain S, Akaike T, Chowdhury EH.

Curr Drug Deliv. 2010 Dec;7(5):389-97. Review.

PMID:
20950269
14.

CNS drug delivery systems: novel approaches.

Pathan SA, Iqbal Z, Zaidi SM, Talegaonkar S, Vohra D, Jain GK, Azeem A, Jain N, Lalani JR, Khar RK, Ahmad FJ.

Recent Pat Drug Deliv Formul. 2009 Jan;3(1):71-89. Review.

PMID:
19149731
15.

Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.

Pardeshi CV, Belgamwar VS.

Expert Opin Drug Deliv. 2013 Jul;10(7):957-72. doi: 10.1517/17425247.2013.790887. Epub 2013 Apr 16. Review.

PMID:
23586809
16.

Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.

Stanimirovic DB, Bani-Yaghoub M, Perkins M, Haqqani AS.

Expert Opin Drug Discov. 2015 Feb;10(2):141-55. doi: 10.1517/17460441.2015.974545. Epub 2014 Nov 12. Review.

PMID:
25388782
17.
18.

Strategy for effective brain drug delivery.

Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, Ahuja A, Akbar M.

Eur J Pharm Sci. 2010 Aug 11;40(5):385-403. doi: 10.1016/j.ejps.2010.05.003. Epub 2010 May 16. Review.

PMID:
20497904
19.

Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.

Pardridge WM.

Expert Opin Ther Targets. 2015;19(8):1059-72. doi: 10.1517/14728222.2015.1042364. Epub 2015 May 2. Review.

PMID:
25936389
20.

Potential approaches for drug delivery to the brain: past, present, and future.

Soni V, Jain A, Khare P, Gulbake A, Jain SK.

Crit Rev Ther Drug Carrier Syst. 2010;27(3):187-236. Review.

PMID:
20540687

Supplemental Content

Support Center